Form D · Biotechnology
Advanced Nanotherapies Inc.
Cleveland, OH · CIK 0001940022
Offering snapshot reported Aug 22, 2022 · SEC filing
- Reported sold
- $640K Offering amount: $640K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $4K Reported outside-investor minimum
- First sale
- Dec 9, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2022 | Initial | $639,969 | No comparison | 10 | SEC filing |
| Aug 22, 2022 | Initial | $9,242,052 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-456457
Source: Form D, filed Aug 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marwan Berrada Sounni | Director, Executive |
| Jerett Creed | Director |
| Regina Groves | Director |
| Mehdi Shishehbor | Director |
| Phillippe Urbain | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10000 Cedar Ave Gcic 8
Cleveland, OH, 44106
Cleveland, OH, 44106